| P50 | author | Nader N Massarweh | Q57081324 |
| P2093 | author name string | Janice N Cormier | |
| | Barry W Feig | |
| | George J Chang | |
| | Y Nancy You | |
| | Yi-Ju Chiang | |
| | Alex B Haynes | |
| P2860 | cites work | What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes | Q29615705 |
| | Comparison of cases captured in the national cancer data base with those in population-based central cancer registries | Q30597272 |
| | The National Cancer Data Base: a powerful initiative to improve cancer care in the United States | Q31142308 |
| | The performance of multiple imputation for missing covariate data within the context of regression relative survival analysis | Q33385717 |
| | Comparison of commission on cancer-approved and -nonapproved hospitals in the United States: implications for studies that use the National Cancer Data Base | Q33487615 |
| | Long-term survival results of surgery alone versus surgery plus 5-fluorouracil and leucovorin for stage II and stage III colon cancer: pooled analysis of NSABP C-01 through C-05. A baseline from which to compare modern adjuvant trials | Q34110004 |
| | Metachronous metastasis- and survival-analysis show prognostic importance of lymphadenectomy for colon carcinomas | Q34207433 |
| | Reasons physicians do not recommend and patients refuse adjuvant chemotherapy for stage III colon cancer: a population based chart review | Q34296147 |
| | Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial | Q34607843 |
| | Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis | Q34629874 |
| | Physician characteristics and variability of erythropoiesis-stimulating agent use among Medicare patients with cancer | Q35187820 |
| | Results of the National Initiative for Cancer Care Quality: how can we improve the quality of cancer care in the United States? | Q36364254 |
| | The National Cancer Data Base. A mechanism for assessment of patient care | Q36761176 |
| | Assessing the utility of cancer-registry-processed cause of death in calculating cancer-specific survival | Q36905055 |
| | Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis. | Q37688548 |
| | Increasing demands for quality measurement | Q38162009 |
| | Association between the Medicare Modernization Act of 2003 and patient wait times and travel distance for chemotherapy | Q39852639 |
| | A comparison of imputation techniques for handling missing predictor values in a risk model with a binary outcome | Q40196067 |
| | Complicated postoperative recovery increases omission, delay and discontinuation of adjuvant chemotherapy in patients with Stage III colon cancer. | Q41969546 |
| | The national cancer data base: past, present, and future | Q42938244 |
| | Variability in length of stay after colorectal surgery: assessment of 182 hospitals in the national surgical quality improvement program | Q45223189 |
| | A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer | Q45253845 |
| | Effect of postoperative complications on adjuvant chemotherapy use for stage III colon cancer | Q46189009 |
| | NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer | Q68536918 |
| | Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma | Q68702101 |
| | Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic | Q69724881 |
| | Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant | Q73153282 |
| | Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators | Q77766534 |
| | Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer | Q79320537 |
| | Surgical complications are associated with omission of chemotherapy for stage III colorectal cancer | Q82999159 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chemotherapy | Q974135 |
| | colon cancer | Q18555025 |
| P304 | page(s) | 312-320 | |
| P577 | publication date | 2015-08-01 | |
| P1433 | published in | Annals of Surgery | Q4767866 |
| P1476 | title | Adequacy of the National Quality Forum's Colon Cancer Adjuvant Chemotherapy Quality Metric: Is 4 Months Soon Enough? | |
| P478 | volume | 262 | |